Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06057051 · ClinicalTrials.gov registry record · NA
Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma
A NA study of Glaucoma, sponsored by Glaukos Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 245
- Enrollment target
- 1
- Study location
NCT06057051 is a NA study of Glaucoma that is actively recruiting participants, run by Glaukos Corporation. The registered enrollment target is 245 participants, below the 908-participant average among 92 other Glaucoma trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06057051, a NA study of Glaucoma, is actively recruiting participants, sponsored by Glaukos Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 245 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment
Conditions Studied
Interventions
- DEVICE iStent Infinite
Study Locations (1)
Ohio
- Glaukos Investigator Site - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 245 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2027-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06057051
The ClinicalTrials.gov registry entry for NCT06057051 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 245 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 908-participant average among 92 other Glaucoma trials with a reported enrollment target (73% lower). The listed sponsor is Glaukos Corporation, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Glaucoma appearing as the primary indexed condition, and to 1 intervention - of which iStent Infinite is the first listed.
NCT06057051 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06057051 about?
NCT06057051 is a clinical study titled "Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma". Prospective, multicenter, single-arm study of the iStent infinite in adult pseudophakic or phakic subjects with mild to moderate primary open angle glaucoma who have not failed conventional medical and surgical treatment
What is the current status of trial NCT06057051?
This trial is currently recruiting. It is a NA study. The enrollment target is 245 participants. The study started on 2023-09-01. Estimated completion is 2027-08.
What conditions does trial NCT06057051 study?
This clinical trial studies the following conditions: Glaucoma.
What interventions are being tested in trial NCT06057051?
The interventions under investigation include: iStent Infinite (DEVICE).
Who is sponsoring clinical trial NCT06057051?
This trial is sponsored by Glaukos Corporation, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06057051 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
Tolerability of an Anesthesia-free Tonometer Tip
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Optic Neuropathies
RECRUITING · NA
-
The Role of Music in Enhancing Attention During Visual Field Exams for Pediatric Glaucoma Patients
RECRUITING · NA
-
Electrical Stimulation for the Treatment of Glaucoma
RECRUITING · NA
-
Hyperbaric Oxygen Therapy for Optic Neuropathies
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.